On The Pen: The Weekly Dose  By  cover art

On The Pen: The Weekly Dose

By: Dave Knapp Man On The Mounjaro
  • Summary

  • Dave Knapp brings you your weekly dose of everything in the news about incretin mimetic therapies, like Zepbound and Mounjaro, Ozempic and Wegovy, and even investigational treatments like CagriSema and Retatrutide!

    © 2024 On The Pen: The Weekly Dose
    Show more Show less
Episodes
  • Threats to Lilly's Zepbound & Mounjaro Printing Press
    May 11 2024

    Send us a Text Message.

    Roche Pharmaceuticals has acquired Carmot Therapeutics along with three obesity and type 2 diabetes candidates: CT-868 / CT-368 / CT-986

    MY WORK RELIES ON YOUR GENEROSITY, BECOME A MEMBER HERE:
    https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/join

    Venmo: OnThePen
    Ca$h App: ManOnMounjaro

    Hello Fresh Free Box:
    https://www.hellofresh.com/pages/raf_lp11?c=FIH-XR3LF83PJ9QE&utm_campaign=referralinvite&utm_medium=clipboard&utm_source=freebies&utm_invitername=David&utm_term=web&discount_comm_id=992270dc-a684-4b10-bd34-da8bb5f811b2

    SOCIAL LINKS
    https://www.tiktok.com/@manonthemounjaro
    https://twitter.com/ManOnMounjaro
    https://instagram.com/manonthemounjaro
    https://facebook.com/manonthemounjaro

    #Zepbound #Maritide #mounjaro

    📲 Contact Me: MounjaroMan@gmail.com
    👉 Link to other GLP-1 MUST HAVE products I mention: https://www.amazon.com/shop/manonthemounjaroonthepen

    📼 PLAYLISTS:
    🖊️ ON THE PEN LIVES:
    https://www.youtube.com/playlist?list=PLtOcNl0C8quVdrWruYSrJpTZPF7jjXKfM
    👀 WATCH MY MOUNJARO JOURNEY IN ORDER:
    https://www.youtube.com/watch?v=aplFxNOv77g&list=PLtOcNl0C8quWo7PWY9j_HilhWIRuedyiO
    😎 NERDS ONLY: LEARN ABOUT OTHER GLP-1 MEDS:
    https://www.youtube.com/playlist?list=PLtOcNl0C8quW-YZuu_DSpt_NS9fVQbMoW
    🚨📰 ALL THE LATEST MOUNJARO NEWS:
    https://www.youtube.com/playlist?list=PLtOcNl0C8quVo0I2YODK-q7cHh4y1r2yB

    Support the Show.

    Thank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit my website at onthepen.com. You can also connect with me on social media, where I go by @manonthemounjaro (or @manonmounjaro on X). Let's continue this journey together towards a healthier and happier life!

    Show more Show less
    11 mins
  • On The Pen: The Weekly Dose 5.7.24
    May 8 2024

    Send us a Text Message.

    MY WORK RELIES ON YOUR GENEROSITY, BECOME A MEMBER HERE: https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/join
    Venmo: OnThePen
    Ca$h App: ManOnMounjaro

    SOCIAL LINKS
    https://www.tiktok.com/@manonthemounjaro
    https://twitter.com/ManOnMounjaro
    https://instagram.com/manonthemounjaro
    https://facebook.com/manonthemounjaro

    #Zepbound #Maritide #mounjaro

    LINKS
    Life Update Blog: Link: https://www.onthepen.com/post/i-m-tired-we-are-tired

    Wegovy released in Canada:
    Link: https://www.msn.com/en-ca/health/other/weight-loss-drug-wegovy-available-in-canada-starting-may-6/ar-AA1o1lZz

    Madison Muller at Bloomberg (friend of our community) had article "Why Weight-Loss Drugs Wegovy, Zepbound Are in Short Supply"
    Link: https://www.bloomberg.com/news/articles/2024-05-02/why-weight-loss-drugs-wegovy-zepbound-are-facing-shortages?srnd=undefined&embedded-checkout=true

    Interviewed on radio station KXEL
    Link: https://www.youtube.com/watch?v=V0YyMwtMuxs

    Optum RX Irony alert:
    Link: https://www.managedhealthcareexecutive.com/view/glp-1-tiering-agreement-reached-says-optum-rx-president

    FTC is challenging Novo Nordisk's patents on Ozempic
    Link: https://www.ftc.gov/system/files/ftc_gov/pdf/novo-nordisk-ozempic-saxenda-victoza-_4302024.pdf

    FTC requested additional information on Novo Nordisk's acquisition of Catalent:
    Link: https://www.msn.com/en-us/money/markets/us-ftc-seeks-more-information-on-novo-nordisk-parent-catalent-deal/ar-AA1o6gHU

    Support the Show.

    Thank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit my website at onthepen.com. You can also connect with me on social media, where I go by @manonthemounjaro (or @manonmounjaro on X). Let's continue this journey together towards a healthier and happier life!

    Show more Show less
    18 mins
  • Lilly Earnings Call: Zepbound and Mounjaro Updates
    May 1 2024

    Send us a Text Message.

    Dave Knapp does a deep dive into todays Eli Lilly earnings call.

    https://www.onthepen.com/post/zepbound-vial-watch-eli-lilly-earnings-q1-2024

    MY WORK RELIES ON YOUR GENEROSITY, BECOME A MEMBER HERE:
    https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/join

    Venmo: OnThePen
    Ca$h App: ManOnMounjaro

    SOCIAL LINKS
    https://www.tiktok.com/@manonthemounjaro
    https://twitter.com/ManOnMounjaro
    https://instagram.com/manonthemounjaro
    https://facebook.com/manonthemounjaro

    Support the Show.

    Thank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit my website at onthepen.com. You can also connect with me on social media, where I go by @manonthemounjaro (or @manonmounjaro on X). Let's continue this journey together towards a healthier and happier life!

    Show more Show less
    28 mins

What listeners say about On The Pen: The Weekly Dose

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.